The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia
Open accessAbstract
Introduction: Synapse dysfunction is emerging as an early pathological event in frontotemporal dementia (FTD), however biomarkers are lacking. We aimed to investigate the value of cerebrospinal fluid (CSF) neuronal pentraxins (NPTXs), a family of proteins involved in homeostatic synapse plasticity, as novel biomarkers in genetic FTD. Methods: We included 106 presymptomatic and 54 symptomatic carriers of a pathogenic mutation in GRN,C9orf72 or MAPT, and 70 healthy non-carriers participating in the Genetic Frontotemporal dementia Initiative (GENFI), all of whom had at least one CSF sample. We measured CSF concentrations of NPTX2 using an in-house ELISA, and NPTX1 and NPTX receptor (NPTXR) by Western blot. We correlated NPTX2 with corresponding clinical and neuroimaging datasets as well as with CSF neurofilament light chain (NfL) using linear regression analyses. Results: Symptomatic mutation carriers had lower NPTX2 concentrations (median 643 pg/mL, IQR (301–872)) than presymptomatic carriers (1003 pg/mL (624–1358), p<0.001) and non-carriers (990 pg/mL (597–1373), p<0.001) (corrected for age). Similar results were found for NPTX1 and NPTXR. Among mutation carriers, NPTX2 concentration correlated with several clinical disease severity measures, NfL and grey matter volume of the frontal, temporal and parietal lobes, insula and whole brain. NPTX2 predicted subsequent decline in phonemic verbal fluency and Clinical Dementia Rating scale plus FTD modules. In longitudinal CSF samples, available in 13 subjects, NPTX2 decreased around symptom onset and in the symptomatic stage. Discussion: We conclude that NPTX2 is a promising synapse-derived disease progression biomarker in genetic FTD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Synaptic dysfunction and loss of synaptic plasticity are fundamental processes that underlie several neurodegenerative disorders from early stages.”
From Synaptic biomarkers in the cerebrospinal fluid associate differentially with classical neuronal biomarkers in patients with Alzheimer’s disease and frontotemporal dementia (2023) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In fact, synaptic pathology has been identified in pre-clinical stages of AD, FTD, dementia with Lewy bodies, and Parkinson’s disease, as well as certain psychiatric disorders [5–7].”
From Synaptic biomarkers in the cerebrospinal fluid associate differentially with classical neuronal biomarkers in patients with Alzheimer’s disease and frontotemporal dementia (2023) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A synaptic protein progressively decreasing with the disease state in genetic FTD is neuronal pentraxin-2 (NPTX2), mainly present as an extracellular protein in the synaptic cleft [7]”
From Synaptic biomarkers in the cerebrospinal fluid associate differentially with classical neuronal biomarkers in patients with Alzheimer’s disease and frontotemporal dementia (2023) · cites this paper as [7]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This is in line with previous findings in FTD mutation carriers for which a negative association between NPTX2 and NfL in CSF was also observed [43].”
The cited source says what the claim attributes to it.
In the citing paper
“In particular, NPTX2 decreases paralleling disease progression and may reflect an association between synaptic disruption and cognitive impairment.”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as van der Ende et al. 2020
12 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A compendium of neuropsychological tests: administration, norms, and commentary
(1991) · Choice Reviews Online · doi:10.5860/choice.29-2400 · Cited by 6,120
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221
Self-citationClassification of primary progressive aphasia and its variants
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141
Self-citationTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Appelhof, B., Bakker, C., Van Duinen-van den Ijssel, J. C. L., Zwijsen, S. A., Smalbrugge, M., Verhey, F. R. J., de Vugt, M. E., Zuidema, S. U., & Koopmans, R. T. C. M. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000477087 · Cited by 2,760
Qualitative Assessment of Verbal Fluency Performance in Frontotemporal Dementia
van den Berg, E., Jiskoot, L. C., Grosveld, M. J. H., van Swieten, J. C., & Papma, J. M. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000477538 · Cited by 2,046
Self-citationNeurofilaments as biomarkers in neurological disorders
Khalil, M., Teunissen, C. E., Otto, M., Piehl, F., Sormani, M. P., Gattringer, T., Barro, C., Kappos, L., Comabella, M., Fazekas, F., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0058-z · Cited by 1,988
Self-citationChurchill, A. J., Gutiérrez, G. D., Singer, R. A., Lorberbaum, D. S., Fischer, K. A., & Sussel, L. (2017) · eLife · doi:10.7554/elife.20010 · Cited by 1,236
Network abnormalities and interneuron dysfunction in Alzheimer disease
Palop, J. J., & Mucke, L. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.141 · Cited by 1,022
Cited by
Root, J., Merino, P., Nuckols, A., Johnson, M., & Kukar, T. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105360 · Cited by 238
Targeting synapse function and loss for treatment of neurodegenerative diseases
Dejanovic, B., Sheng, M., & Hanson, J. E. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00823-1 · Cited by 191
Zhou, J., Wade, S. D., Graykowski, D., Xiao, M.-F., Zhao, B., Giannini, L. A. A., Hanson, J. E., van Swieten, J. C., Sheng, M., Worley, P. F., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adf0141 · Cited by 152
Self-citationFluid biomarkers in frontotemporal dementia: past, present and future
Swift, I. J., Sogorb-Esteve, A., Heller, C., Synofzik, M., Otto, M., Graff, C., Galimberti, D., Todd, E., Heslegrave, A. J., van der Ende, E. L., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-323520 · Cited by 122
Self-citationGómez de San José, N., Massa, F., Halbgebauer, S., Oeckl, P., Steinacker, P., & Otto, M. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-021-02411-2 · Cited by 112
Self-citation
Metadata
- Authors
- van der Ende, E. L., Xiao, M., Xu, D., Poos, J. M., Panman, J. L., Jiskoot, L. C., Meeter, L. H., Dopper, E. G., Papma, J. M., Heller, C., Convery, R., Moore, K., Bocchetta, M., Neason, M., Peakman, G., Cash, D. M., Teunissen, C. E., Graff, C., Synofzik, M., Moreno, F., Finger, E., Sánchez-Valle, R., Vandenberghe, R., Laforce Jr, R., Masellis, M., Tartaglia, M. C., Rowe, J. B., Butler, C. R., Ducharme, S., Gerhard, A., Danek, A., Levin, J., Pijnenburg, Y. A., Otto, M., Borroni, B., Tagliavini, F., de Mendonca, A., Santana, I., Galimberti, D., Seelaar, H., Rohrer, J. D., Worley, P. F., & van Swieten, J. C.
- Affiliations
- Johns Hopkins University (US)
- Erasmus MC (NL)
- Leiden University Medical Center (NL)
- University College London (GB)
- UCL Queen Square Institute of Neurology (GB)
- Amsterdam Neuroscience (NL)
- Karolinska University Hospital (SE)
- German Center for Neurodegenerative Diseases (DE)
- Western University (CA)
- KU Leuven (BE)
- Sunnybrook Health Science Centre (CA)
- University of Toronto (CA)
- University of Cambridge (GB)
- University of Oxford (GB)
- Montreal Neurological Institute and Hospital (CA)
- Klinik und Poliklinik für Neurologie (DE)
- Universität Ulm (DE)
- University of Brescia (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Centro de Neurociências e Biologia Celular (PT)
- University of Milan (IT)
- ORCID
- van der Ende, Emma L
- Xu, Desheng
- Poos, Jackie M
- Panman, Jessica L
- Jiskoot, Lize C
- Meeter, Lieke H
- Dopper, Elise GP
- Papma, Janne M
- Heller, Carolin
- Convery, Rhian
- Moore, Katrina
- Bocchetta, Martina
- Neason, Mollie
- Peakman, Georgia
- Cash, David M
- Teunissen, Charlotte E
- Graff, Caroline
- Synofzik, Matthis
- Finger, Elizabeth
- Vandenberghe, Rik
- Masellis, Mario
- Tartaglia, Maria Carmela
- Rowe, James B
- Butler, Christopher R
- Ducharme, Simon
- Danek, Adrian
- Levin, Johannes
- Pijnenburg, Yolande AL
- Otto, Markus
- Borroni, Barbara
- Tagliavini, Fabrizio
- Santana, Isabel
- Galimberti, Daniela
- Seelaar, Harro
- Rohrer, Jonathan D
- Worley, Paul F
- van Swieten, John C
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2020-04-09
- Volume
- 91
- Issue
- 6
- Pages
- 612-621
- ISSN
- 0022-3050 (ISSN-L)
- 1468-330X
- PMC
- PMC7279197
- OpenAlex
- W3015522591
- Cited by
- 94
- References
- 45
- Citations by year
- 2026: 7 · 2025: 20 · 2024: 17 · 2023: 15 · 2022: 16 · 2021: 15 · 2020: 4
- FWCI
- 9.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Neurology Neurosurgery & Psychiatry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
- Institutional Research Information System (Università degli Studi di Trento) (submittedVersion, cc-by)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, cc-by)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion, cc-by)
- UCL Discovery (University College London) (submittedVersion)
- Open access LMU (Ludwid Maxmilian's Universitat Munchen) (submittedVersion, cc-by)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- DZNE Pub (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Apollo
- Funders
- Deutsche Forschungsgemeinschaft
- Horizon 2020 Framework Programme (779357)
- Schorling foundation
- NIHR Rare Disease Translational Research Collaboration (BRC149/NS/MH)
- Stockholms Läns Landsting
- Munich Cluster for Systems Neurology (EXC 2145 SyNergy 390857198)
- Swedish Demensfonden
- Swedish FTD Initiative
- The Bluefield Project to Cure Frontotemporal Dementia
- Stichting Dioraphte (1402 1300)
- Swedish Alzheimer Foundation
- Stiftelsen för Gamla Tjänarinnor
- Vetenskapsrådet (2015-02926, 2018-02754, 529-2014-7504)
- Hjärnfonden
- MRC UK (MR/M023664/1)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (733050103, 733050813)
- Alzheimer Nederland (733050103, 733050813)
- StratNeuro
- European Joint Programme - Neurodegenerative Disease Research (733051024, 733051042)
- Mady Browaeys Fonds voor Onderzoek naar Frontotemporale Degeneratie
- Karolinska Institutet Doctoral funding
- Fundacio Marato de TV3 (20143810)
- MRC Clinician Scientist Fellowship (MR/M008525/1)
- Wellcome Trust (103838)
- Alzheimer's Society (As-PhD-2015-005)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- NPTX2, NPTX1, cerebrospinal fluid biomarkers, genetic frontotemporal dementia, presymptomatic mutation carriers, synaptic dysfunction, neurofilament light chain, gray matter volume, disease progression, phonemic fluency, Clinical Dementia Rating
- MeSH terms
- Pentraxins, Adult, Aged, C-Reactive Protein, Female, Heterozygote, Humans, Male, Middle Aged, Nerve Tissue Proteins, Biomarkers, Neurofilament Proteins, Disease Progression, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia. https://app.cochat.ai/papers/10.1136/jnnp-2019-322493
- The paper
- van der Ende, E. L., Xiao, M., Xu, D., Poos, J. M., Panman, J. L., Jiskoot, L. C., Meeter, L. H., Dopper, E. G., Papma, J. M., Heller, C., Convery, R., Moore, K., Bocchetta, M., Neason, M., Peakman, G., Cash, D. M., Teunissen, C. E., Graff, C., Synofzik, M., . . . van Swieten, J. C. (2020). Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia. Journal of Neurology, Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2019-322493
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.